(Q46742981)

24 December 2017

title

Cinacalcet is efficacious in pediatric dialysis patients (English)

1 reference

24 December 2017

main subject

renal dialysis

0 references

author name string

Douglas M Silverstein

1

1 reference

24 December 2017

Kanwal K Kher

2

1 reference

24 December 2017

Asha Moudgil

3

1 reference

24 December 2017

Mona Khurana

4

1 reference

24 December 2017

Jennifer Wilcox

5

1 reference

24 December 2017

Kathleen Moylan

6

1 reference

24 December 2017

publication date

21 February 2008

1 reference

24 December 2017

published in

Pediatric Nephrology

1 reference

24 December 2017

volume

23

1 reference

24 December 2017

issue

10

1 reference

24 December 2017

page(s)

1817-1822

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s00467-007-0742-5

exact match

0 references

cites work

Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis

1 reference

12 December 2020

Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials

1 reference

12 December 2020

1 reference

12 December 2020

Meta-analysis of biochemical and patient-level effects of calcimimetic therapy

1 reference

12 December 2020

Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.

1 reference

12 December 2020

Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis

1 reference

12 December 2020

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

1 reference

12 December 2020

Effects of Ca2+ sensing receptor activation in the growth plate

1 reference

12 December 2020

Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease

1 reference

12 December 2020

The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

Chondrocyte calcium-sensing receptor expression is up-regulated in early guinea pig knee osteoarthritis and modulates PTHrP, MMP-13, and TIMP-3 expression.

1 reference

12 December 2020

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

1 reference

12 December 2020

Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate

1 reference

12 December 2020

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

12 December 2020

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

1 reference

12 December 2020

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

1 reference

12 December 2020

"High-dose" calcitriol for control of renal osteodystrophy in children on CAPD.

1 reference

12 December 2020

Soft tissue calcification in pediatric patients with end-stage renal disease

1 reference

12 December 2020

Calcimimetics--fooling the calcium receptor

1 reference

12 December 2020

Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means

1 reference

12 December 2020

Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients

1 reference

12 December 2020

Therapy of secondary hyperparathyroidism with 19-nor-1alpha,25-dihydroxyvitamin D2

1 reference

12 December 2020

Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy

1 reference

12 December 2020

The renal bone diseases in children treated with dialysis

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

Renal osteodystrophy in dialyzed children

1 reference

12 December 2020

Oral calcium carbonate as phosphate-binder in infants and children with chronic renal failure

1 reference

12 December 2020

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

1 reference

12 December 2020

First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl.

1 reference

12 December 2020

Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication

1 reference

12 December 2020

Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.

1 reference

12 December 2020

A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.

1 reference

12 December 2020

Natural logarithmic estimates of Kt/V in the pediatric hemodialysis population.

1 reference

12 December 2020

Calcimimetic agents: review and perspectives

1 reference

12 December 2020

Role of the calcium-sensing receptor in parathyroid gland physiology

1 reference

12 December 2020

Arterial calcifications and bone histomorphometry in end-stage renal disease

1 reference

12 December 2020

10.1007/S00467-007-0742-5

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017